Zeitschrift

The Journal of Haemophilia Practice's Cover Image

The Journal of Haemophilia Practice

Zeitschriftendaten
access type Open Access
License
Format
Zeitschrift
eISSN
2055-3390
Erstveröffentlichung
22 Dec 2017
Sprachen
Englisch
Journal Subjects
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin, Pharmazie, Pharmakologie

The Journal of Haemophilia Practice is an international, open-access, peer-reviewed journal that accepts papers from all members of the multidisciplinary bleeding disorders care team.
Any manuscript that is relevant to current haemophilia practice will be considered for publication by our editorial review team. To this end, we positively welcome:

  • Original research
  • Case reports
  • Case Series
  • Reviews in any field of bleeding disorders that are of relevance to current clinical practice
  • Clinical Updates that describe current advances in any clinical field related to bleeding disorders
  • Editorials that address a particular topic of current interest.

All manuscripts submitted to The Journal of Haemophilia Practice will first be subject to a technical review, including a quality check of all the files submitted, including tables, figures and references. This will include a plagiarism check (see below). Manuscripts will then be reviewed by the Editor-in-Chief, who will decide whether or not to proceed to peer-review by members of our editorial board and invited experts. The identity of the reviewers will not be disclosed to the authors. The review procedure will result in one of three decisions:

  • Accept
  • Accept subject to revision
  • Reject

The editorial decision will be communicated to the authors as soon as the review process has been finalized. In case of revisions, the revised article will be sent to the reviewers who will decide on a new recommendation for revision, acceptance or rejection.

The estimated time from the submission to first decision is approximately 4-6 weeks, and from the final revision to acceptance is approximately 2 weeks. Prior to publication, the corresponding author will receive a proof of their article in order to confirm the accuracy of the text or suggest modifications.

Archiving

Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.

Plagiarism Policy

The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

Editor-in-Chief
Dr Kate Khair, Great Ormond Street Hospital, London, UK

Managing Editor
Mike Holland, Haemnet, UK

Editorial Advisory Board
Tami Barazani-Brutman, Sheba Medical Center at Sheba, Tel Hashomer Hospital, Israel
Paul Batty, Queen Mary University of London, UK, and Queen’s University, Ontario, Canada
Greig Blamey, Health Sciences Center, University of Alberta, Canada
Erica Crilly, British Columbia Children's Hospital, Vancouver, Canada
Janine Furmedge, The Royal Children’s Hospital Haemophilia Centre, Melbourne, Australia
Rich Gorman, Brighton and Sussex Medical School, UK
Chris Guelcher, Children’s National Hospital, Washington, USA
Chris Harrington, Royal Free Hospital, London, UK
Cathy Harrison, Sheffield Haemophilia & Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK
Dan Hart, The Royal London Hospital and Barts Health NHS Trust, London, UK
Adam Jones, University of Sunderland, UK
Radek Kaczmarek, Indiana University School of Medicine, USA
Sebastien Lobet, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Paul McLaughlin, Royal Free Hospital, London, UK
Greta Mulders, Erasmus University Medical Center, Rotterdam, The Netherlands
James Munn, University of Michigan Hemophilia and Coagulation Disorders Program, Michigan, USA
Declan Noone, European Haemophilia Association, Brussels
Jamie O'Hara, University of Chester, Cheshire, UK
Debra Pollard, Royal Free Hospital, London, UK
BJ Ramsay, Wellington Haemophilia Centre, Wellington, New Zealand
Dakota J. Rosenfelt, PharmD, Missouri, US
Sylvia von Mackensen, Institute of Medical Psychology at the University Medical Centre, Hamburg, Germany
Linda Myrin Westesson, Sahlgrenska University Hospital, Gothenburg, Sweden
Michelle Witkop, National Hemophilia Foundation, USA

Technical Editor
Kathryn Jenner, Haemnet, UK

Publisher
De Gruyter Poland
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15

The Journal of Haemophilia Practice ist in den folgenden Services indiziert:

  • Baidu Scholar
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • EBSCO Discovery Service
  • Google Scholar
  • J-Gate
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • MyScienceWork
  • Naver Academic
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • QOAM (Quality Open Access Market)
  • ReadCube
  • Semantic Scholar
  • Summon (ProQuest)
  • TDNet
  • WorldCat (OCLC)

Manuscripts should be submitted via the journal’s Scholar One Manuscripts site: mc04.manuscriptcentral.com/jhaempract.

You will need to log in. If you are using Scholar One for the first time, use the ‘Create an Account’ link.

One you have logged in, select the ‘Author’ tab. You should then follow the on-screen instructions – the system will guide you through the process of manuscript submission. Alongside the manuscript, accompanying figures and tables, and general information about the manuscript, you will be asked to provide:

  • The names of suggested reviewers (optional)
  • A cover letter signed on behalf of all co-authors by the corresponding author
  • An Open Access License agreement, completed by the corresponding author on behalf of all co-authors (available via the ‘Instructions and Forms’ tab on the journal’s Scholar One Manuscripts site: mc04.manuscriptcentral.com/jhaempract)
  • Details of any conflicts of interest
  • Confirmation that informed consent has been obtained where appropriate.

After submitting your manuscript, you will receive a confirmation email.

You can check on the status of your manuscript at any time by logging in to your Scholar One account.

The journal will notify you by email when a decision has been made on your manuscript.

Manuscript types

The Journal of Haemophilia Practice accepts

  • Original research
  • Case reports
  • Case series
  • Reviews in any field of bleeding disorders of relevance to current clinical practice
  • Clinical Updates that describe current advances in any clinical field related to bleeding disorders
  • Editorials that address a particular topic of current interest.

Please note that case reports should meet the standards outlined in the CARE Case Report Guidelines. Authors submitting case reports are advised to consult the CARE Checklist.

Manuscript format

Wordcount

Although we do not specify wordcounts for articles, we recommend the following:

  • For shorter papers, e.g. case reports and small cohort studies: 1,000–3,000 words
  • For reviews, larger studies and qualitative studies, which require explanation of methodologies: 3,000–7,000 words.

Title

The title should be short and informative. For case reports, the words ‘case report’ should be included in the title.

Authors

Full author names and affiliation should be given. An ORCID iD for each author should be provided where available.

Abstract

For original articles, a short abstract should be provided using the following headings: Background or Introduction, Aims, Methods, Results, Conclusion.

Keywords

Submissions should include 3–6 keywords for indexing purposes.

Reference style

Journal titles should be abbreviated according to the style of Index Medicus and spelled out in full if not listed in Index Medicus. These can be looked up in the NLM Catalog.

The DOI (digital object identifier) associated with journal articles should be provided where available.

Where there are six or more authors associated with a reference, the first three should be listed, followed by ‘et al.’

Datasets should be cited using the format outlined by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository/archive; Version (if relevant); Persistent identifier, e.g. DOI (if available).

Reference style examples:

  • Reference to an article:

Khair K, Klukowska A, Myrin Westesson L, et al. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia 2019; 25(3): 416-423. doi: 10.1111/hae.13736.

  • Reference to a book:

Jones P. Living with Haemophilia. 2002. Oxford: Oxford University Press.

  • Reference to a chapter in a book:

Escobar MA, Roberts HR. Less common congenital disorders of hemostasis. In: Kitchens CS, ed. Consultative Hemostasis and Thrombosis, 3rd edn. 2013. Philadelphia, PA: W.B. Saunders Company.

  • Reference to a webpage/online resource:

European Medicines Agency (EMA). European Public Assessment Report (EPAR) NovoSeven Summary for the Public. 2009. Available from http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000074/human_med_000936.jsp&mid=WC0b01ac058001d124 (accessed 9 September 2013).

Figures and tables

Please provide tables and figures at the end of the manuscript or as a separate file.

Informed consent

People who are reported in studies have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, dates of birth or hospital numbers, should not be published in written descriptions, photographs or pedigrees unless the information is essential for scientific purposes and the person (or parent or guardian) gives written informed consent for publication.

Informed consent for this purpose requires that an identifiable person be shown the manuscript to be submitted for publication. Authors should disclose to these participants whether any potential identifiable material might be available via the internet or in print after publication.

Each implicated individual’s consent should be written and archived with the authors. If the patient is a minor or lacks capacity to consent, the written informed consent of a parent or guardian must be given. If the person in the case study is deceased, written consent must be sought from a relative. Without consent, a case report may be considered for publication if the patient is sufficiently anonymised according to ICMJE guidelines. Nonessential identifying details should always be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Consent must be mentioned in the manuscript. We reserve the right to request copies of consent documentation. The Editor will make the final determination of what constitutes personally identifiable information on a case-by-case basis.

Open Access Statement

The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.

Open Access License

Zeitschriftendaten
access type Open Access
License
Format
Zeitschrift
eISSN
2055-3390
Erstveröffentlichung
22 Dec 2017
Sprachen
Englisch
Journal Subjects
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin, Pharmazie, Pharmakologie

Plan your remote conference with Sciendo